NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New siRNA drug aims to halt liver damage in NASH patients
Disease control OngoingThis study tests an experimental drug called VSA006 in 48 Chinese adults with NASH, a type of fatty liver disease that can lead to scarring. The drug works by targeting a gene linked to liver protection. Researchers want to see if it can improve liver health and reduce fat withou…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New drug cocktail aims to halt liver scarring in NASH patients
Disease control OngoingThis study tests whether a combination of two experimental drugs can improve liver health in adults with NASH, a fatty liver disease that can lead to scarring. About 228 participants with mild to moderate liver scarring will take the drugs for up to a year. The main goal is to se…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New scanner aims to spot fatty liver without needles
Diagnosis TerminatedThis study was designed to test a new device that uses sound and heat to measure fat in the liver. It would compare the device's accuracy to standard MRI scans in adults with or suspected of having non-alcoholic fatty liver disease. The goal was to see if this simpler method coul…
Matched conditions: NASH
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated May 26, 2026 04:04 UTC
-
New scan could spot fatty liver in kids without needles
Diagnosis OngoingThis study tests new MRI and ultrasound techniques to measure liver fat in children aged 10-14, both with obesity and healthy weight. The goal is to see if these imaging methods work well and are practical for diagnosing non-alcoholic fatty liver disease (NAFLD) without invasive …
Matched conditions: NASH
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated May 18, 2026 12:04 UTC